1. Home
  2. CHCO vs EVO Comparison

CHCO vs EVO Comparison

Compare CHCO & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo City Holding Company

CHCO

City Holding Company

HOLD

Current Price

$123.76

Market Cap

1.7B

Sector

Finance

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$2.98

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHCO
EVO
Founded
1957
1993
Country
United States
Germany
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.1B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
CHCO
EVO
Price
$123.76
$2.98
Analyst Decision
Hold
Strong Buy
Analyst Count
3
1
Target Price
$128.33
$7.00
AVG Volume (30 Days)
92.2K
107.8K
Earning Date
01-22-2026
11-05-2025
Dividend Yield
2.78%
N/A
EPS Growth
11.27
N/A
EPS
8.68
N/A
Revenue
$307,880,000.00
$887,396,457.00
Revenue This Year
$10.45
N/A
Revenue Next Year
$3.18
$8.80
P/E Ratio
$14.40
N/A
Revenue Growth
6.33
N/A
52 Week Low
$102.22
$2.84
52 Week High
$133.59
$5.10

Technical Indicators

Market Signals
Indicator
CHCO
EVO
Relative Strength Index (RSI) 64.26 40.58
Support Level $124.15 $2.94
Resistance Level $127.35 $3.09
Average True Range (ATR) 2.27 0.09
MACD 0.46 0.01
Stochastic Oscillator 82.67 26.47

Price Performance

Historical Comparison
CHCO
EVO

About CHCO City Holding Company

City Holding Co is a financial holding company. The company conducts its principal activities through its wholly-owned subsidiary, City National Bank of West Virginia (City National). Through the bank, it provides banking, trust and investment management, and other financial solutions through its network of banking offices located in the states of West Virginia, Virginia, southeastern Ohio, and Kentucky. It offers various products and services such as overdraft facilities, savings accounts, credit cards and debit cards, loans for various purposes, investment advisory, securities brokerage, insurance products, and others. The company's business activities are currently limited to one reportable business segment, which is community banking.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: